The potent LPCAT3 inhibitor, (R)-HTS-3, demonstrated partial protection against ferroptosis (252)
Clinical Risks of Combining GLP-1 Medications with Cannabis The primary documented risks include unpredictable nausea and vomiting, delayed gastric emptying, impaired glucose monitoring, and potential hepatic stress
Pre-hydration protocol Drinking 8-16 ounces of water 15-20 minutes before taking drops, then stopping all fluids 5 minutes before administration, creates an interesting dynamic
Enhanced GABAergic network and receptor function in pediatric cortical dysplasia type IIB compared with tuberous sclerosis complex
Tirzepatide follows a similar pattern with steps at 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg, requiring potentially six escalation periods
Fitzpatrick TB, Becker SW Jr, Lerner AB, Montgomery H (1950) Tyrosinase in human skin: demonstration of its presence and of its role in human melanin formation